Vascular access: concepts for the 1990s.
Fan PY, Schwab SJ.
J Am Soc Nephrol. 1992 Jul;3(1):1-11. doi: 10.1681/ASN.V311.
Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman.
D'Souza PC, Kumar S, Kakaria A, Al-Sukaiti R, Al-Baimani K, Hamid RS, Mittal AK, Al-Balushi M, Burney IA, Al-Moundhri MS.
Sultan Qaboos Univ Med J. 2021 Feb;21(1):e103-e109. doi: 10.18295/squmj.2021.21.01.014. Epub 2021 Mar 15.
Preoperative vascular access evaluation for haemodialysis patients.
Kosa SD, Al-Jaishi AA, Moist L, Lok CE.
Cochrane Database Syst Rev. 2015 Sep 30;2015(9):CD007013. doi: 10.1002/14651858.CD007013.pub2.
Pathogenesis of ocular toxoplasmosis.
Smith JR, Ashander LM, Arruda SL, Cordeiro CA, Lie S, Rochet E, Belfort R Jr, Furtado JM.
Prog Retin Eye Res. 2021 Mar;81:100882. doi: 10.1016/j.preteyeres.2020.100882. Epub 2020 Jul 24.
Infection at the vascular front: A delicate balance between defense and pathology.
Zhou J, Wang D, Yan B.
Microb Pathog. 2026 Feb;211:108261. doi: 10.1016/j.micpath.2025.108261. Epub 2025 Dec 23.
[Temporary vascular access for haemodialysis: is infection still the most important complication?].
Barracca A, Pili GF, Spina M, Murgia MG, Menneas AP, Manca O.
G Ital Nefrol. 2002 Jan-Feb;19(1):44-8.
Vessel health and preservation: Vascular access key risk considerations.
Moureau N.
Enferm Clin (Engl Ed). 2025 Jun-Jul;35(4):502302. doi: 10.1016/j.enfcle.2025.502302. Epub 2025 Jul 3.
Hemodialysis catheters.
Ponikvar R.
Ther Apher Dial. 2005 Jun;9(3):218-22. doi: 10.1111/j.1774-9987.2005.00258.x.
Access in therapeutic apheresis.
Stegmayr B, Wikdahl AM.
Ther Apher Dial. 2003 Apr;7(2):209-14. doi: 10.1046/j.1526-0968.2003.00035.x.
Vascular access for hemodialysis.
Haimov M.
Surg Gynecol Obstet. 1975 Oct;141(4):619-25.
